Samir B. Amin
Samir B. Amin
Postdoctoral fellow, The Jackson Laboratory for Genomic Medicine
Verified email at - Homepage
Cited by
Cited by
The Cancer Genome Atlas Pan-Cancer analysis project
TCGAR Network
Nature Genetics 45 (10), 1113-1120, 2013
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
The Molecular Taxonomy of Primary Prostate Cancer
CGA Network
Cell 163 (4), 1011-25, 2015
Systematic analysis of telomere length and somatic alterations in 31 cancer types
FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ...
Nature genetics 49 (3), 349-357, 2017
Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
RH Prabhala, D Pelluru, M Fulciniti, HK Prabhala, P Nanjappa, W Song, ...
Blood, The Journal of the American Society of Hematology 115 (26), 5385-5392, 2010
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
TumorFusions: an integrative resource for cancer-associated transcript fusions
X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ...
Nucleic acids research 46 (D1), D1144-D1149, 2018
Integrative analysis of gene and miRNA expression profiles with transcription factor–miRNA feed-forward loops identifies regulators in human cancers
Z Yan, PK Shah, SB Amin, MK Samur, N Huang, X Wang, V Misra, H Ji, ...
Nucleic acids research 40 (17), e135-e135, 2012
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ...
Nature 542 (7641), 362-366, 2017
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Neuro-oncology 20 (7), 873-884, 2018
KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer
H Alam, M Tang, M Maitituoheti, SS Dhar, M Kumar, CY Han, CR Ambati, ...
Cancer cell 37 (4), 599-617. e7, 2020
Gene expression profile alone is inadequate in predicting complete response in multiple myeloma
SB Amin, WK Yip, S Minvielle, A Broyl, Y Li, B Hanlon, D Swanson, ...
Leukemia 28 (11), 2229-2234, 2014
miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis
J Xue, A Zhou, Y Wu, SA Morris, K Lin, S Amin, R Verhaak, G Fuller, K Xie, ...
Cancer research 76 (14), 4293-4304, 2016
Systematic epigenomic analysis reveals chromatin states associated with melanoma progression
P Fiziev, KC Akdemir, JP Miller, EZ Keung, NS Samant, S Sharma, ...
Cell reports 19 (4), 875-889, 2017
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
Z Tian, J Zhao, YT Tai, SB Amin, Y Hu, AJ Berger, P Richardson, ...
Blood, The Journal of the American Society of Hematology 120 (19), 3958-3967, 2012
Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer
B Rondinelli, D Rosano, E Antonini, M Frenquelli, L Montanini, DC Huang, ...
The Journal of clinical investigation 125 (12), 4625-4637, 2015
Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure
KC Akdemir, VT Le, JM Kim, S Killcoyne, DA King, YP Lin, Y Tian, A Inoue, ...
Nature Genetics 52 (11), 1178-1188, 2020
Significant biological role of sp1 transactivation in multiple myeloma
M Fulciniti, S Amin, P Nanjappa, S Rodig, R Prabhala, C Li, S Minvielle, ...
Clinical Cancer Research 17 (20), 6500-6509, 2011
p53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors
A Carugo, R Minelli, L Sapio, M Soeung, F Carbone, FS Robinson, ...
Cancer Cell 35 (2), 204-220. e9, 2019
The system can't perform the operation now. Try again later.
Articles 1–20